Clinical Trials

Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations

by ClinicalTrialsFeed • 2011/05/23 • 0 Comments

Status: Recruiting, Condition Summary: Amaurosis of Leber; Retinal Diseases

← Femtosecond Laser Technology Will Likely Be Integrated Into An Increasing Number Of Procedures

FDA Schedules Advisory Committee Meeting To Discuss BLA For VEGF Trap-Eye For The Treatment Of Wet Age-Related Macular Degeneration →